These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 9171281
21. Interactive Grand Rounds. Case 3: management of cyclosporine-induced hirsutism and gingival overgrowth in a heart transplant recipient. Rosario AM, Young JB. J Heart Lung Transplant; 2000 Sep; 19(9):907-8. PubMed ID: 11202924 [No Abstract] [Full Text] [Related]
22. Gingival overgrowth in a renal transplant recipient using cyclosporine A. Gonçalves SC, Díaz-Serrano KV, de Queiroz AM, Palioto DB, Faria G. J Dent Child (Chic); 2008 Sep; 75(3):313-7. PubMed ID: 19040821 [Abstract] [Full Text] [Related]
23. [Drug-induced gingival hyperplasia]. Nohl F, Ferrari P. Ther Umsch; 1998 Sep; 55(9):573-5. PubMed ID: 9789475 [Abstract] [Full Text] [Related]
24. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients. Barten MJ, Rahmel A, Garbade J, Bold A, Bittner HB, Dhein S, Mohr FW, Gummert JF. Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162 [Abstract] [Full Text] [Related]
25. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. Furlong T, Storb R, Anasetti C, Appelbaum FR, Deeg HJ, Doney K, Martin P, Sullivan K, Witherspoon R, Nash RA. Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278 [Abstract] [Full Text] [Related]
29. The impact on biochemical profiles and allograft function for patients converted from cyclosporine to tacrolimus after clinical heart transplantation. Wang CH, Chou NK, Ko WJ, Chi NH, Tsao CI, Wang SS. Transplant Proc; 2008 Oct; 40(8):2600-2. PubMed ID: 18929812 [Abstract] [Full Text] [Related]
30. Drug-induced gingival hyperplasia and its management--a literature review. Botha PJ. J Dent Assoc S Afr; 1997 Nov; 52(11):659-64. PubMed ID: 9589004 [No Abstract] [Full Text] [Related]
35. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ, Rossi AF, Courtney M, Gelb BD. J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [Abstract] [Full Text] [Related]
36. Massive gingival hyperplasia due to cyclosporine. Sánchez López JD, Cariati P, Rodríguez I. Med Clin (Barc); 2019 Apr 18; 152(8):e47. PubMed ID: 30220468 [No Abstract] [Full Text] [Related]
37. Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus. Zadrazil J, Horak P, Zahalkova J, Strebl P, Horcicka V, Krejci K, Bachleda P, Dedochova J, Valkovsky I. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar 18; 153(1):67-73. PubMed ID: 19365530 [Abstract] [Full Text] [Related]
38. [Ciclosporine A-induced gingival hyperplasia]. Ramalho VL, Ramalho HJ, Cipullo JP, Burdmann EA. Rev Assoc Med Bras (1992); 2003 Mar 18; 49(2):210-3. PubMed ID: 12886402 [Abstract] [Full Text] [Related]